Number of shares outstanding for Takeda Pharmaceutical (TAK)

Number of shares outstanding as of December 2024 : 3,137,830,958

According to Takeda Pharmaceutical's latest financial reports and stock price the company's current number of shares outstanding is 3,137,830,958. At the end of 2024 the company had 3,137,830,958 shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.

Shares outstanding history for Takeda Pharmaceutical from 2008 to 2024

Shares Outstanding at the end of each year

Year	Shares Outstanding	Change
2024	3.13 B	0.23%
2023	3.13 B	0.69%
2022	3.10 B	-0.68%
2021	3.13 B	0.12%
2020	3.12 B	0.36%
2019	3.11 B	98.57%
2018	1.56 B	0.43%
2017	1.56 B	0.04%
2016	1.56 B	-0.34%
2015	1.56 B	-0.29%
2014	1.57 B	-0.48%
2013	1.57 B	0.01%
2012	1.57 B	0%
2011	1.57 B	0%
2010	1.57 B	-0%
2009	1.57 B	0%
2008	1.57 B

Shares Outstanding for similar companies or competitors

Company	Shares Outstanding	differencediff.	Country
Johnson & Johnson JNJ	2,407,298,000	-23.28%	🇺🇸 USA
Sanofi SNY	2,506,000,000	-20.14%	🇫🇷 France
Pfizer PFE	5,667,000,000	80.60%	🇺🇸 USA
Novartis NVS	2,012,000,000	-35.88%	🇨🇭 Switzerland
Seagen SGEN	188,135,000	-94.00%	🇺🇸 USA
Dr. Reddy's RDY	833,046,160	-73.45%	🇮🇳 India
Amgen AMGN	537,000,000	-82.89%	🇺🇸 USA
GlaxoSmithKline GSK	2,040,000,000	-34.99%	🇬🇧 UK
Merck MRK	2,532,030,145	-19.31%	🇺🇸 USA

What is the market capitalization of a company?

The market capitalization sometimes referred as Marketcap, is the value of a publicly listed company.
In most cases it can be easily calculated by multiplying the share price with the amount of outstanding shares.

DISCLAIMER

CompaniesMarketCap is not associated in any way with CoinMarketCap.com
Stock prices are delayed, the delay can range from a few minutes to several hours.
Company logos are from the CompaniesLogo.com logo database and belong to their respective copyright holders. Companies Marketcap displays them for editorial purposes only.

Contact

For inquiries or if you want to report a problem write to hello@8marketcap.com

Links

- Privacy policy

- Terms and conditions